Systane Solution/ Drops
NDC Package 0065-1432-01
Package Information
Systane (polyethylene glycol 400 and propylene glycol) solution/ dropses is instill 1 or 2 drops in the affected eye(s) as needed. This formulation utilizes a solution/ drops delivery system. Marketed by Alcon Laboratories, Inc., this product is identified by NDC 0065-1432 and is authorized under FDA application M018.
Identification & Billing
- RxCUI: 477589 - polyethylene glycol 400, 0.4 % / propylene glycol 0.3 % Ophthalmic Solution
- RxCUI: 477589 - polyethylene glycol 400 4 MG/ML / propylene glycol 3 MG/ML Ophthalmic Solution
- RxCUI: 477589 - PEG 400 0.4 % / propylene glycol 0.3 % Ophthalmic Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0065 - Alcon Laboratories, Inc.
- 0065-1432 - Systane
- 0065-1432-01 - 24 VIAL in 1 CARTON / .4 mL in 1 VIAL
- 0065-1432 - Systane
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0065-1432). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0065-1432-01 identifies a specific commercial package of 24 vial in 1 carton / .4 ml in 1 vial of Systane Ultra, a human over the counter drug labeled by Alcon Laboratories, Inc.. This solution/ drops is formulated for ophthalmic use and contains polyethylene glycol 400; propylene glycol as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Alcon Laboratories, Inc. on July 27, 2009. The current certification is valid through December 31, 2026.
How is this Alcon Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00065143201. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.
